| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/19/2012 | US20120014873 Peptides whose uptake by cells is controllable |
| 01/19/2012 | US20120014869 Muc18 targeting peptides |
| 01/19/2012 | CA2805728A1 Microparticles comprising a small heat-shock protein |
| 01/19/2012 | CA2805338A1 Peptide for use in the treatment of breast cancer and/or bone metastases |
| 01/19/2012 | CA2805325A1 Insulin-lipid complex, preparation method therefor, and preparation thereof |
| 01/19/2012 | CA2805228A1 A liquid formulation of long-acting human growth hormone conjugate |
| 01/19/2012 | CA2805112A1 Humanized antibodies targeting the ec1 domain of cadherin-11 and related compositions and methods |
| 01/19/2012 | CA2804795A1 Romidepsin solid forms and uses thereof |
| 01/19/2012 | CA2804753A1 Anti-angiogenic agent and methods of using such agent |
| 01/19/2012 | CA2804697A1 Formulation comprising a type b lantibiotic |
| 01/19/2012 | CA2804278A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases |
| 01/19/2012 | CA2803322A1 Fermented soya based mixture comprising isoflavones-aglycones, equol and lunasin, process for the preparation thereof and related uses in food, medical and cosmetic fields |
| 01/19/2012 | CA2802207A1 Materials and method for suppressing inflammatory and neuropathic pain |
| 01/18/2012 | EP2407536A1 ADP-ribosyl transferase fusion variant proteins |
| 01/18/2012 | EP2407470A2 Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of HCV replication |
| 01/18/2012 | EP2407176A1 Ameliorating agent for chronic obstructive pulmonary disease |
| 01/18/2012 | EP2407175A1 Agents with angiogenic and wound healing activity |
| 01/18/2012 | EP2407174A1 Progression inhibitor or prophylactic agent for atherosclerosis, blood cholesterol level-lowering agent, and functional food or food for specified health uses |
| 01/18/2012 | EP2407173A1 Method and compositions to induce apoptosis of tumoral cells expressing SHH |
| 01/18/2012 | EP2407172A1 Peptide sequences and compositions |
| 01/18/2012 | EP2407171A2 Compositions and methods for the treatment of ophthalmic disease |
| 01/18/2012 | EP2407167A2 Therapeutic agent for neurodegenerative disease |
| 01/18/2012 | EP2407165A1 Antioxidant agent |
| 01/18/2012 | EP2406399A1 Mirac proteins |
| 01/18/2012 | EP2406396A2 A genotyping tool for improving the prognostic and clinical management of ms patients |
| 01/18/2012 | EP2406282A1 Interleukin-21 variants having antagonistic binding to the il-21 receptor |
| 01/18/2012 | EP2406281A2 Bone morphogenetic protein 2 (bmp2) variants with reduced bmp antagonist sensitivity |
| 01/18/2012 | EP2406279A2 Compositions and methods for prevention and treatment of neurodegenerative diseases |
| 01/18/2012 | EP2406277A1 New strain of salmonella enterica s. typhimurium, its use and a method to obtain a therapeutic vaccine vector |
| 01/18/2012 | EP2406275A1 Peptide promoting cell adhesion and migration |
| 01/18/2012 | EP2406238A1 Metal ion chelating agents, methods for preparing same and uses thereof |
| 01/18/2012 | EP2405936A1 Injectable biomaterials |
| 01/18/2012 | EP2405934A1 Treatment of diabetes and metabolic syndrome |
| 01/18/2012 | EP2405933A1 Method of treating heart failure |
| 01/18/2012 | EP2405932A2 Sparc angiogenic domain and methods of use |
| 01/18/2012 | EP2405931A2 Treatment of diseases related to hyperactivity of the complement system |
| 01/18/2012 | EP2405930A1 Use of hasf as a protective agent against ischemic tissue damage |
| 01/18/2012 | EP2405929A1 Treatment methods for autoimmune disorders |
| 01/18/2012 | EP2405928A1 Treatment and diagnostic methods for hypersensitive disorders |
| 01/18/2012 | EP2405927A1 Methods for the treatment or prevention of systemic sclerosis |
| 01/18/2012 | EP2405925A2 Use of serine protease inhibitors in the treatment of neutropenia |
| 01/18/2012 | EP2405920A1 Novel therapy for anxiety |
| 01/18/2012 | EP2405909A1 Compositions and methods for elimination of gram-negative bacteria |
| 01/18/2012 | EP2405904A2 Method of treating eczema |
| 01/18/2012 | EP2405893A1 Oil-based preparation containing antiprotozoal triazines and anthelmintic cyclodepsipeptides |
| 01/18/2012 | EP2405749A1 Low frequency glatiramer acetate therapy |
| 01/18/2012 | EP2327413A9 Pharmaceutical composition comprising FGF18 and IL-1 antagonist and method of use |
| 01/18/2012 | EP2271665B1 Highly bridged peptides from actinomadura namibiensis |
| 01/18/2012 | EP1743940B1 Cardioinhibitory/ antihypertensive novel endogenous physiologically active peptide |
| 01/18/2012 | EP1726310B1 Drug for cancer therapy |
| 01/18/2012 | EP1713780B1 Novel inhibitors of glutaminyl cyclase |
| 01/18/2012 | EP1704234B1 Production of glucagon like peptide 2 and analogs |
| 01/18/2012 | EP1696945B1 Self-assembling peptide amphiphiles and related methods for growth factor delivery |
| 01/18/2012 | EP1692522B1 A reference solution |
| 01/18/2012 | EP1635651B9 Methods for hyperthyroidism in a cat and composition comprising limited iodine |
| 01/18/2012 | EP1633390B1 Stabilized pharmaceutical glp-1 peptide compositions |
| 01/18/2012 | EP1530481B1 Enzyme containing composition, process of producing said composition and its use |
| 01/18/2012 | EP1456385B1 Growth hormone fusion protein |
| 01/18/2012 | EP1454138B1 Immunocytokines with modulated selectivity |
| 01/18/2012 | EP1446489B1 Intact minicells as vectors for dna transfer and gene therapy in vitro and in vivo |
| 01/18/2012 | EP1440092B1 Photoactivatable composition and the use of same |
| 01/18/2012 | EP1430114B1 Prolactin induced increase in neural stem cell numbers and therapeutical use thereof |
| 01/18/2012 | EP1390075B1 Chemotherapeutic induction of egr-1 promoter activity in gene therapy |
| 01/18/2012 | EP1292709B1 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| 01/18/2012 | EP1257822B1 Her-2 binding antagonists |
| 01/18/2012 | CN102325884A Hypo-immunogenic streptavidin and use thereof |
| 01/18/2012 | CN102325880A Serine protease derivatives and uses in the prevention or the treatment of blood coagulation disorders |
| 01/18/2012 | CN102325792A Means and methods for manufacturing highly pure neurotoxin |
| 01/18/2012 | CN102325789A Visfatin therapeutic agents for treatment of acne and other conditions |
| 01/18/2012 | CN102325788A Cancer-targeting peptides and uses thereof in cancer therapy |
| 01/18/2012 | CN102325545A Cytotoxic conjugates having neuropeptide y receptor binding compound |
| 01/18/2012 | CN102325544A Analogues of neuropeptide y having proline substitution at position 34 |
| 01/18/2012 | CN102325543A Novel composition containing n2-(1-oxohexadecyl)-lysyl-valyl-lysine, for treatment of acne rosacea and symptom thereof |
| 01/18/2012 | CN102325542A Compositions and methods to prevent cancer with cupredoxins |
| 01/18/2012 | CN102325541A Aqueous transfer buffer |
| 01/18/2012 | CN102325540A Analogues of neuropeptide y having at least one synthetic amino acid substitution |
| 01/18/2012 | CN102325539A Amide based glucagon superfamily peptide prodrugs |
| 01/18/2012 | CN102321628A C-type agglutinin gene of procambarus clarkia as well as preparation method and applications thereof |
| 01/18/2012 | CN102321584A Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence |
| 01/18/2012 | CN102321187A Method for extracting whole peptidoglycan from bifidobacterium longum NQ-1501 |
| 01/18/2012 | CN102321182A Composite antibacterial peptide produced by bacillus natto NT-6 and production method thereof |
| 01/18/2012 | CN102321181A Cyclin D/CDK4 (Cyclin-Dependent Kinase) originated chimeric polypeptide with anti-tumor activity and application as anti-tumor medicament |
| 01/18/2012 | CN102321178A Novel gonadotropin releasing hormone oriented fusion protein mutant |
| 01/18/2012 | CN102321170A Liraglutide variant and conjugate thereof |
| 01/18/2012 | CN102321165A Hainantoxin-XXI and application of hainantoxin-XXI in preparing analgesic and anti-inflammatory drugs and in preparing reagent for studying TRPV1 channel |
| 01/18/2012 | CN102321164A Preparation method and application of insect natural antibacterial peptide products |
| 01/18/2012 | CN102321158A Polypeptide for preventing cell DNA synthesis and inhibiting cell proliferation and application |
| 01/18/2012 | CN102321157A Hexapeptide with antioxidant activity and separation method as well as application thereof |
| 01/18/2012 | CN102321156A Novel thymopentin compound and composition powder injection thereof |
| 01/18/2012 | CN102321155A Tumor necrosis factor (TNF) binding peptide and TNFR1 blocking peptide, and application thereof in treatment of ulcerative colitis |
| 01/18/2012 | CN102319437A Polymer conjugates of interferon-beta with enhanced biological potency |
| 01/18/2012 | CN102319425A Wound healing agent and radix astragali composite freeze-dried platelet gel kit for preparing wound healing agent |
| 01/18/2012 | CN102319424A Formulation of medicament for breeding palaemon carinicauda and application method |
| 01/18/2012 | CN102319423A Health care product for treating habitual constipation caused by internal heat due to yin deficiency |
| 01/18/2012 | CN102319422A Long - acting formulations of insulins |
| 01/18/2012 | CN102319421A Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 01/18/2012 | CN102319420A Application of soft-shelled turtle peptide in preparation of medicines |
| 01/18/2012 | CN102319419A Application of turtle peptide in pharmacy |
| 01/18/2012 | CN102319418A Buserelin preparation and preparation method thereof |
| 01/18/2012 | CN102319417A Moderating the effect of endotoxins |